Prostate Cancer
Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer.
September 29, 2023
The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer.
September 28, 2023
The utility of [18F]Fluciclovine PET/CT in Evaluating Nonmetastatic Castrate Resistant Prostate Cancer Patients (nmCRPCp): Diagnostic performance and Impact on Management.
September 28, 2023
Association Between Urologist Merit-based Incentive Payment System Performance and Quality of Prostate Cancer Care.
September 28, 2023
Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis.
September 28, 2023
Precision intervention for prostate cancer: Re-evaluating who is at risk.
September 28, 2023
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance.
September 28, 2023
Low-Value Prostate Cancer Screening Among Young Men With Private Insurance.
September 27, 2023
Prognostic value of pretreatment inflammatory markers in localised prostate cancer before radical prostatectomy.
September 27, 2023
Geriatric assessment - What should be done and considered before starting therapy of mHSPC and mCRPC?
September 27, 2023
Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia.
September 26, 2023
Rare Genetic Drivers of Lethal Prostate Cancer.
September 26, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
September 26, 2023